Interview with Professor Juan Miguel Bayo Fina from the Faculty of Biomedical Sciences of the Universidad Austral A CONICET and Translational Medicine Research Associate Researcher spoke on Radio Punto Uno in the province of Salta about a new experimental therapeutic strategy that could benefit patients with severe liver disease. In a significant advance for Argentine translational science, researchers from the Laboratory of Experimental Hepatology and Gene Therapy (IIMT) identified for the first time an effective therapeutic pathway to treat fulminant hepatitis, a condition that can cause death in up to 40% of cases without transplantation.